Thyroid Lymphoma
A thyroid that is enlarging quickly, especially with Hashimoto's thyroiditis?
Primary thyroid lymphoma is rare, but it is often curable when it is diagnosed early and the biopsy is done correctly. Dr. Shifrin, an endocrine surgeon who performs more than 400 thyroid and parathyroid operations a year, can evaluate a rapidly growing thyroid mass, obtain the right biopsy, and coordinate treatment with hematology and oncology.
Call (732) 792-5003 or request a consultation. Office: 55 Willow Ln, Suite 101, Englishtown, NJ.
Jump to: What is it Symptoms Diagnosis Staging Treatment Prognosis Case images References
Reviewed by Alexander Shifrin, MD, Director of Endocrine Surgery, CentraState Medical Center. No single U.S. guideline is devoted to thyroid lymphoma; this page summarizes current reviews and registry and multicenter studies, and the British Thyroid Association guidance.
What is primary thyroid lymphoma?
Primary thyroid lymphoma (PTL) is a lymphoma (a cancer of lymphocytes, a type of white blood cell) that involves only the thyroid, or the thyroid and nearby neck lymph nodes. It is rare, about 1 to 5% of thyroid cancers and about 2% of lymphomas that start outside the lymph nodes. It affects about 2 people per million per year, mostly women, usually in their 50s to 80s, with a peak around age 60.
- Most are B-cell non-Hodgkin lymphomas. The two main types are diffuse large B-cell lymphoma (DLBCL), which is aggressive but responds well to treatment, and MALT (marginal zone) lymphoma, which is slow-growing. Some tumors are mixed.
- Hashimoto's thyroiditis is the main risk factor, present in the majority of patients. People with Hashimoto's thyroiditis have a risk of thyroid lymphoma estimated at 40 to 80 times higher than the general population. The absolute risk is still very small. It is thought that long-term immune stimulation of the thyroid leads to the abnormal lymphocytes.
- Thyroid lymphoma is not a thyroid-cell cancer, so it is treated very differently from thyroid cancer, and an operation to remove the thyroid is usually not the treatment. A correct diagnosis therefore matters.
What are the symptoms?
- A rapidly enlarging, usually painless neck mass, often firm and smooth, on one or both sides. This is the most common sign.
- Pressure symptoms in about one-third of patients: trouble swallowing, shortness of breath, noisy breathing (stridor), and hoarseness. Some patients have neck pain (up to about 12%).
- Most patients have normal thyroid function; some have hypothyroidism, usually from the underlying Hashimoto's thyroiditis.
- B symptoms (fever, drenching night sweats, weight loss) are uncommon, in about 10%.
How is it diagnosed?
Often a very dark (hypoechoic) mass
FNA with flow cytometry, or core biopsy
PET/CT or CT, blood tests
Treatment plan
- Ultrasound is the first test for any thyroid mass. See thyroid nodules.
- Biopsy. A fine-needle aspiration (FNA) is the usual first test. Lymphoma cells are large, loosely held cells. Hashimoto's thyroiditis looks similar under the microscope and may be present in the same gland, so a sample can miss the lymphoma. Adding flow cytometry and immunostains to the FNA improves accuracy, and a core needle biopsy or open (surgical) biopsy may be needed to confirm the diagnosis and the exact subtype, which decides the treatment. MALT and mixed lymphomas are particularly difficult to identify on cell appearance alone.
- In a 2024 multicenter review, only about 13% of patients were diagnosed before surgery, so there is room to diagnose earlier by needle biopsy when lymphoma is suspected.
- Staging uses the Ann Arbor system, with CT of the head, neck, chest, abdomen and pelvis, or FDG-PET/CT, plus blood tests (including LDH) and, in some patients, a bone marrow biopsy.
- Thyroid lymphoma can look like the aggressive anaplastic thyroid carcinoma, and the two are treated very differently, which is why pathology review by experts is important.
Staging
| Ann Arbor stage | Meaning |
|---|---|
| IE | Confined to the thyroid (about half of patients) |
| IIE | Thyroid plus nearby neck lymph nodes (about 45% in older series) |
| IIIE | Lymph nodes on both sides of the diaphragm |
| IV | Spread to other organs or bone marrow |
"Primary" thyroid lymphoma by definition is stage IE or IIE. Poorer outlook is linked to higher stage, a tumor over about 10 cm, growth into the chest (mediastinum), fast growth, and swallowing or breathing problems.
How is it treated?
Thyroid lymphoma is very sensitive to chemotherapy and radiation. Treatment is directed by a hematologist-oncologist and radiation oncologist, depending on the subtype and stage.
| Type | Usual treatment |
|---|---|
| Diffuse large B-cell lymphoma (and mixed types) | Combined treatment: chemotherapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP), usually followed by involved-site radiation to the neck. Combined treatment has done better than radiation or chemotherapy alone in several studies. |
| MALT lymphoma, stage IE or IIE | Local treatment is often enough: radiation alone, or surgery (thyroidectomy, sometimes found after an operation for another reason). Adding radiation after surgery has not clearly improved results over radiation alone. Rituximab-based drug therapy is used in selected cases. |
| Advanced MALT (beyond the neck) | Systemic therapy, similar to lymphoma elsewhere |
The surgeon's role. Extensive surgery does not improve survival in thyroid lymphoma. Surgery is used to obtain tissue for diagnosis, and, in patients with a tumor that is blocking the windpipe or esophagus, to relieve pressure. Dr. Shifrin can evaluate you promptly, obtain an adequate biopsy, protect your airway if needed, and coordinate with your oncology team. After treatment, thyroid function is monitored, because radiation and Hashimoto's thyroiditis can lead to hypothyroidism needing levothyroxine.
What is the prognosis?
- MALT lymphoma has an excellent outlook, with long-term survival over 90% in most series.
- Diffuse large B-cell lymphoma responds well to modern combined treatment. In several series about three of four patients are alive at 5 years, with higher rates for stage IE disease. Results vary between studies and depend on stage, tumor size, and symptoms.
- Outlook is better when the disease is found while still confined to the thyroid (stage IE) and treated with combined therapy.
Many older numbers published in medical literature came from the era before rituximab. Your oncology team can give you figures that apply to your type and stage.
Case images

Figure 1. Patient with B-cell thyroid lymphoma

Figure 2. CT scan of the same patient: thyroid lymphoma presented as a very large thyroid gland with compression and deviation of the trachea
Related pages
References
- Stein SA, Wartofsky L. Primary thyroid lymphoma: a clinical review. J Clin Endocrinol Metab. 2013;98(8):3131-3138.
- Onal C, Li YX, Miller RC, et al. Treatment results and prognostic factors in primary thyroid lymphoma patients: a Rare Cancer Network study. Ann Oncol. 2011;22(1):156-164. doi:10.1093/annonc/mdq310
- Chai YJ, Hong JH, Koo DH, et al. Clinicopathological characteristics and treatment outcomes of 38 cases of primary thyroid lymphoma: a multicenter study. Ann Surg Treat Res. 2015;89(6):295-299.
- Primary thyroid lymphoma: a multi-center retrospective review. Am J Surg. 2024 (diagnosis made before surgery in 13% of patients).
- Alzouebi M, Goepel J, Horsman J, Hancock B. Primary thyroid lymphoma: the 40-year experience of a UK lymphoma treatment centre. Int J Oncol. 2012;40(6):2075-2080.
- Sakorafas GH, Kokkoris P, Farley DR. Primary thyroid lymphoma: diagnostic and therapeutic dilemmas. Surg Oncol. 2010;19(4):e124-e129.
- Widder S, Pasieka J. Primary thyroid lymphomas. Curr Treat Options Oncol. 2004;5:307-313.
- Perros P, Boelaert K, Colley S, et al. Guidelines for the management of thyroid cancer (British Thyroid Association). Clin Endocrinol. 2014;81(Suppl 1):1-122.
- Bible KC, Kebebew E, Brierley J, et al. 2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer. Thyroid. 2021;31(3):337-386. (differential diagnosis) doi:10.1089/thy.2020.0944
This page is for general education and does not replace a medical evaluation.

Home





